Technology Transfer is an expression that most people in the pharmaceutical industry are familiar with or have some experience of.  However, ask someone to explain what it is in simple terms and you will probably receive a variety of answers.  Paul Smith at Agilent Technologies explains the need to define a formal TT process arises because of the regulatory, business and ultimately patient risks that an unsuccessful transfer may represent.
https://international-pharma.com/wp-content/uploads/2014/01/Strategies.pdf